Matches in Nanopublications for { ?s ?p "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _6 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _6 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _6 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.
- _4 value "Thus, although beta-adrenergic agonists, such as isoproterenol, increase cardiomyocyte membrane- associated cAMP and PKA activity and have positive inotropic effects, other activators of cardiomyocyte adenylyl cyclase activity, such as prostaglandin E1, fail to increase membrane-associated cAMP levels and have only weak inotropic effects (Buxton and Brunton, 1985; Movsesian, 2000)." provenance.